Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
NCT06030804
Summary
Along with aging population, cancer incidence and mortality are increasing. However, despite advances in oncology and surgery, long-term survival of cancer patients is far from optimal. Dexmedetomidine is a highly selective alpha 2 adrenergic receptor agonist with sedative, analgesic, and anxiolytic effects. Studies showed that perioperative use of dexmedetomidine reduces delirium and some non-delirium complications after surgery. In long-term follow-up studies of older patients who, for other reasons, were randomized to receive either dexmedetomidine or placebo during intra- or postoperative period, dexmedetomidine use was associated with improved long-term survival. This multicenter randomized trial aims to investigate the effect of perioperative dexmedetomidine on long-term outcomes in older patients undergoing cancer surgery.
Eligibility
Inclusion criteria: 1. Aged 60 years or older. 2. Scheduled to undergo radical surgery for cancer under general anesthesia, with an expected surgical duration of 2 hours or longer. 3. Required patient-controlled intravenous analgesia after surgery. Exclusion criteria: 1. Inability to communicate preoperatively due to visual, auditory, verbal. or other reasons. 2. Surgery for breast cancer or intracranial tumor. 3. Preoperative severe sinus bradycardia (\<50 beats per minute), sick sinus syndrome,or second-degree or above atrioventricular block without pacemaker. 4. Severe hepatic dysfunction (Child-Pugh class C). 5. Severe renal dysfunction (requirement of renal replacement therapy before surgery). 6. Enrolled in other clinical studies.
Conditions5
Interventions1
Related trials
- Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia — Second Affiliated Hospital of Wenzhou Medical University
- Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA — Poznan University of Medical Sciences
- Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block — Fayoum University
- Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery — University of Novi Sad
- Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect — Alexandria University
- Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient — Dharmais National Cancer Center Hospital
- Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia — University Hospital, Montpellier
- Intranasal Dexmedetomidine vs Oral Midazolam for Premedication in Pediatric Surgery — Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06030804